Users should be aware of the potential risk of thyroid C-cell tumors, as indicated in animal studies
Consumers overall high satisfaction with these medications for weight loss has been tempered primarily by concerns about side effects, weight gain if discontinued, and cost, said Kathy Risch, SVP, Shopper Insights and Thought Leadership, Acosta Group
For those seeking effective supplementation, acetyl glutathione offers enhanced bioavailability, ensuring optimal absorption
Rob Davis, Merck CEO (Jeenah Moon/Bloomberg via Getty Images) December 18, 2024 10:18 AM EST Deals China Pharma Mercks long-awaited obesity move is an oral GLP-1 from China Kyle LaHucik Biotech Correspondent Merck is finally making a move in obesity by licensing an oral GLP-1 candidate, though its happening years after some of its big pharma peers
Concerns over more severe adverse effects, including pancreatitis and possible thyroid tumors, may further deter both patients and healthcare providers from utilizing these medications